VYOME HOLDINGS INC
HINDNASDAQπ #4778 by market capEarnings Nov 24US Equity
$1.76β² $0.00 (+0.28%)
Pre-market Β· at closeTrack HIND
Get earnings, price moves & breaking news on Telegram
24hβ² 0.3%
7dβ² 0.3%
14dβΌ 7.9%
30dβΌ 15.0%
ytdβΌ 48.8%
1yβΌ 67.6%
π¦Market Cap
$12M
Small Cap
πRevenue Growth (YoY)
-98.0%
Declining
πGross Margin
52.7%
Healthy
π΅FCF Margin
β
βοΈP/S Ratio
92.0x
Expensive
Otter Score
β
Insufficient data
Trading Snapshot
- Day Range
- $1.76 β $1.76
- 52-Week Range
- $1.70 β $6.56
- Volume (shares)
- 100
- Avg Volume (shares)
- β
- Shares Outstanding
- 7.0M
- Next Earnings
- 2026-11-24
Fundamentals Snapshot
- Annual Revenue
- $319,714
- Last Q Revenue
- $26,955
- P/E Ratio
- β
- P/S Ratio
- 92.0x
- EPS (TTM)
- $-3.51
- Dividend Yield
- β
- Dilution (1yr)
- +20172.4%
VYOME HOLDINGS INC
HINDFinancial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$320KβΌ β96.0% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
64.7%β² +2.4% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isnβt profitable yet.
β$3MβΌ β64.5% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
β$4MβΌ β15.3% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing ownerβs slice.
5.9Mβ² +20172.4% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$5Mβ² +$5M YoY
About VYOME HOLDINGS INC
Vyome Holdings, Inc. operates as a healthcare firm currently in its clinical development phase, concentrating on the creation of innovative medicinal treatments designed to address both immuno-inflammatory conditions and infrequent disorders. Founded in 2017, the company extends its market reach throughout the United States and into global territories, headquartered in Princeton, New Jersey.
π¦¦
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
πQualityβ
β
β
β
β
πGrowthβ
β
β
β
β
βοΈValuationβ
β
β
β
β
π§Dilutionβ
β
β
β
β
Overall Score
Insufficient data
β/100
Analyst Ratings
βConsensus
Buy
9 analysts
Strong Buy2
Buy6
Hold1
Sell0
Strong Sell0
Ratings as of Oct 2026
Latest News & Updates
News unavailable.